Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Letrozole × CNS × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 359 Gynecologic 40 Sarcoma 5 Genitourinary 5 Other solid neoplasm 4 Gastrointestinal 4 Tumor-Agnostic 3 Thoracic 3 Other 2 Lymphoid 2 Head & Neck 2 Endocrine 2 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 527 Radiotherapy 347 Bevacizumab 217 Magnetic Resonance Spectroscopy 191 Radiosurgery 146 Cyclophosphamide 146 Carboplatin 133 Etoposide 109 Radiation 106 Irinotecan 97 Vincristine 90 Cisplatin 81 Filgrastim 80 pembrolizumab 76 Specimen Handling 75 Nivolumab 72 Lomustine 72 Surgical Procedures, Operative 68 Topotecan 57 Melphalan 50 Carmustine 49 Radiotherapy, Intensity-Modulated 48 Granulocyte Colony-Stimulating Factor 45 Doxorubicin 45 sargramostim 44 Peripheral Blood Stem Cell Transplantation 43 Blood Specimen Collection 43 Chemotherapy, Adjuvant 42 Isotretinoin 41 Erlotinib Hydrochloride 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2023-12-13

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡